VIDEO: Consider cost in anastrozole vs. tamoxifen for DCIS
Posted on: 12/06/2015 - 13:20
CHICAGO – Anastrozole may top tamoxifen in reducing the risk of disease recurrence in postmenopausal ductal carcinoma in situ (DCIS), particularly in younger women, but which drug holds a cost...
Field of Interest: Oncology
Type: News Item